AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,010.00p
   
  • Change Today:
      41.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 1,065,537
  • Market Cap: £155,185m
  • RiskGrade: 123
  • Beta: 0.87

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
07-Nov-24 Shore Capital Buy 9,725.00p - - Reiteration
07-Nov-24 JP Morgan Cazenove Overweight 9,725.00p - 14,000.00p Reiteration
16-Sep-24 JP Morgan Cazenove Overweight 12,016.00p - - Reiteration
03-Sep-24 Deutsche Hold 13,190.00p - 11,000.00p Reiteration
02-Sep-24 Berenberg Bank Buy 13,276.00p - 15,000.00p Reiteration
05-Aug-24 Berenberg Bank Buy 12,458.00p - 15,000.00p Reiteration
25-Jul-24 Shore Capital Buy 12,060.00p - - Reiteration
12-Jul-24 Shore Capital Buy 12,260.00p - - Reiteration
02-Jul-24 Jefferies Hold 12,086.00p 71.00p 74.00p Reiteration
18-Jun-24 Deutsche Hold 12,416.00p - 11,000.00p Reiteration
07-Jun-24 Berenberg Bank Buy 12,556.00p 13,000.00p 15,000.00p Reiteration
04-Jun-24 JP Morgan Cazenove Overweight 12,404.00p - - Reiteration
28-May-24 Citigroup Buy 12,028.00p - - Reiteration
21-May-24 Shore Capital Buy 12,364.00p - - Reiteration
21-May-24 Jefferies Hold 12,364.00p - 11,300.00p Reiteration
21-May-24 JP Morgan Cazenove Overweight 12,364.00p - - Reiteration
03-May-24 Berenberg Bank Buy 12,050.00p 12,000.00p 13,000.00p Reiteration
23-Apr-24 Deutsche Hold 11,268.00p - 10,500.00p Reiteration
15-Apr-24 Shore Capital Buy 11,024.00p - - Reiteration
15-Apr-24 Deutsche Hold 11,024.00p - - Upgrade
08-Apr-24 Barclays Overweight 10,610.00p - 12,500.00p Reiteration
05-Apr-24 Shore Capital Buy 10,620.00p - - Reiteration
04-Apr-24 JP Morgan Cazenove Overweight 10,736.00p - 1,300.00p Reiteration
13-Mar-24 Berenberg Bank Buy 10,458.00p - 120.00p Reiteration
12-Mar-24 Deutsche Sell 10,436.00p - - Reiteration
27-Feb-24 Deutsche Sell 10,328.00p - 9,500.00p Reiteration
20-Feb-24 JP Morgan Cazenove Overweight 10,204.00p - 12,500.00p Reiteration
19-Feb-24 Berenberg Bank Buy 10,418.00p 125.00p 120.00p Reiteration
16-Feb-24 Jefferies Hold 10,094.00p 11,000.00p 11,000.00p Reiteration
12-Feb-24 Barclays Outperform 9,501.00p 135.00p 125.00p Reiteration
12-Feb-24 UBS Sell 9,501.00p 10,700.00p 9,900.00p Reiteration
12-Feb-24 Stifel Buy 9,501.00p 125.00p 120.00p Reiteration
12-Feb-24 BMO Capital Markets Outperform 9,501.00p - - Reiteration
08-Feb-24 Shore Capital Buy 9,823.00p - - Reiteration
28-Nov-23 Citigroup Buy 9,900.00p - - Reiteration
27-Nov-23 Jefferies Buy 9,976.00p 13,000.00p 12,500.00p Reiteration
21-Nov-23 Berenberg Bank Buy 10,192.00p - 12,500.00p Reiteration
20-Nov-23 Barclays Buy 10,106.00p - 13,500.00p Reiteration
17-Nov-23 JP Morgan Cazenove Overweight 10,260.00p - - Reiteration
09-Nov-23 Shore Capital Buy 10,436.00p - - Reiteration
27-Oct-23 Berenberg Bank Buy 10,124.00p 133.00p 125.00p Reiteration
24-Oct-23 Shore Capital Buy 10,438.00p - - Reiteration
03-Oct-23 Deutsche Hold 10,908.00p - - Reiteration
02-Oct-23 Citigroup Buy 10,950.00p - - Reiteration
29-Sep-23 Shore Capital Buy 11,102.00p - - Reiteration
22-Sep-23 Berenberg Bank Buy 11,046.00p - 133.00p Reiteration
12-Sep-23 Barclays Overweight 10,684.00p - 13,500.00p Reiteration
05-Sep-23 Deutsche Hold 10,736.00p - 11,000.00p Reiteration
04-Sep-23 Berenberg Bank Buy 10,690.00p - 13,300.00p Reiteration
30-Aug-23 Shore Capital Buy 10,734.00p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,010.00p
Change Today 41.00p
% Change 0.41 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 1,065,537
Shares Issued 1,550.30m
Market Cap £155,185m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
12:41 290 @ 10,010.00p
12:41 85 @ 10,010.00p
12:41 48 @ 10,010.00p
12:41 30 @ 10,010.00p
12:41 88 @ 10,010.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page